摘要 |
The present invention provides dinucleoside boranophosphate derivatives of the general formula I: wherein X and X' each independently is an unsubstituted or substituted purine or pyrimidine residue; Y and Y' each independently is H or OH; Z<SUB>1 </SUB>to Z<SUB>5 </SUB>each independently is O<SUP>-</SUP> or BH<SUB>3</SUB><SUP>-</SUP>, but excluding the compounds wherein Z<SUB>1 </SUB>to Z<SUB>5 </SUB>are each O<SUP>-</SUP>; W<SUB>1 </SUB>to W<SUB>4 </SUB>each independently is O, CH<SUB>2</SUB>, NH or C(Halogen)<SUB>2</SUB>; n and n' each independently is 0 or 1; m is 3, 4 or 5; and M<SUP>+</SUP> represents a pharmaceutically acceptable cation, and to pharmaceutical compositions thereof. These dinucleoside boranophosphates are useful for prevention or treatment of diseases or disorders modulated by P2Y receptors such as type 2 diabetes, cystic fibrosis and cancer. |